The study further confirmed that inhibition of Nogo-A/NgR1 expression at the gene level or antagonism of its function at the protein level could reduce Rho A/ROCK signaling pathway activation and promote neurological recovery in post-stroke animals (97, 102). Here, RTN4R is linked to stroke disorder.